nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Sphingolipid metabolism—COL4A3BP—lung cancer	0.0296	0.126	CbGpPWpGaD
Zanamivir—NEU2—Sialic acid metabolism—ST3GAL5—lung cancer	0.0281	0.119	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—ST3GAL5—lung cancer	0.0196	0.0829	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—ST3GAL5—lung cancer	0.016	0.0677	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—ST3GAL5—lung cancer	0.0102	0.0431	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—B4GALT5—lung cancer	0.00905	0.0384	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.0056	0.0237	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ST3GAL5—lung cancer	0.00525	0.0223	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ADAMTS1—lung cancer	0.00468	0.0199	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—B4GALT5—lung cancer	0.00468	0.0199	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.00424	0.018	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF2B4—lung cancer	0.00411	0.0174	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—KHSRP—lung cancer	0.00335	0.0142	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.0033	0.014	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—KIF5B—lung cancer	0.00323	0.0137	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF2B5—lung cancer	0.00293	0.0124	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—COL4A3BP—lung cancer	0.00249	0.0106	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AZIN2—lung cancer	0.00249	0.0106	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ST3GAL5—lung cancer	0.00249	0.0106	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.00232	0.00986	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00225	0.00955	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ADAMTS1—lung cancer	0.00222	0.00942	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—B4GALT5—lung cancer	0.00222	0.00942	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ATP5H—lung cancer	0.00212	0.00899	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00195	0.00826	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GRP—lung cancer	0.00195	0.00825	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PLBD1—lung cancer	0.00189	0.00801	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.00186	0.00788	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HSD17B10—lung cancer	0.00173	0.00733	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ATF3—lung cancer	0.0017	0.00719	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CKB—lung cancer	0.00161	0.00681	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—LMNA—lung cancer	0.00152	0.00646	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CNDP2—lung cancer	0.00151	0.00641	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTM2—lung cancer	0.00151	0.00641	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MTMR3—lung cancer	0.00147	0.00623	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PGAM1—lung cancer	0.00143	0.00607	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP2A7—lung cancer	0.00137	0.00579	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SDC4—lung cancer	0.00134	0.00567	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—RRM1—lung cancer	0.00122	0.00516	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA3—lung cancer	0.00122	0.00516	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—B4GALT5—lung cancer	0.00114	0.00486	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA4—lung cancer	0.00111	0.00472	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.00109	0.00462	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA2—lung cancer	0.00109	0.0046	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA1—lung cancer	0.00105	0.00444	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCC3—lung cancer	0.00104	0.00439	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AKR1C1—lung cancer	0.001	0.00425	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—UGT1A1—lung cancer	0.000973	0.00413	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GNG11—lung cancer	0.000939	0.00398	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000934	0.00396	CbGpPWpGaD
Zanamivir—Syncope—Paclitaxel—lung cancer	0.000916	0.0012	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—lung cancer	0.000915	0.0012	CcSEcCtD
Zanamivir—Rash—Topotecan—lung cancer	0.000913	0.00119	CcSEcCtD
Zanamivir—Hypersensitivity—Vinorelbine—lung cancer	0.000913	0.00119	CcSEcCtD
Zanamivir—Dermatitis—Topotecan—lung cancer	0.000912	0.00119	CcSEcCtD
Zanamivir—Vomiting—Erlotinib—lung cancer	0.000911	0.00119	CcSEcCtD
Zanamivir—Dyspnoea—Irinotecan—lung cancer	0.000911	0.00119	CcSEcCtD
Zanamivir—Cough—Etoposide—lung cancer	0.000909	0.00119	CcSEcCtD
Zanamivir—Headache—Topotecan—lung cancer	0.000907	0.00119	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000907	0.00119	CcSEcCtD
Zanamivir—Rash—Erlotinib—lung cancer	0.000903	0.00118	CcSEcCtD
Zanamivir—Dermatitis—Erlotinib—lung cancer	0.000903	0.00118	CcSEcCtD
Zanamivir—Convulsion—Etoposide—lung cancer	0.000902	0.00118	CcSEcCtD
Zanamivir—Skin disorder—Cisplatin—lung cancer	0.000901	0.00118	CcSEcCtD
Zanamivir—Headache—Erlotinib—lung cancer	0.000898	0.00117	CcSEcCtD
Zanamivir—Loss of consciousness—Paclitaxel—lung cancer	0.000897	0.00117	CcSEcCtD
Zanamivir—Asthma—Methotrexate—lung cancer	0.000895	0.00117	CcSEcCtD
Zanamivir—NEU2—Metabolism—ALDOA—lung cancer	0.000894	0.00379	CbGpPWpGaD
Zanamivir—Chills—Docetaxel—lung cancer	0.000892	0.00117	CcSEcCtD
Zanamivir—Cough—Paclitaxel—lung cancer	0.000891	0.00117	CcSEcCtD
Zanamivir—Asthenia—Vinorelbine—lung cancer	0.000889	0.00116	CcSEcCtD
Zanamivir—Decreased appetite—Irinotecan—lung cancer	0.000888	0.00116	CcSEcCtD
Zanamivir—Arrhythmia—Docetaxel—lung cancer	0.000888	0.00116	CcSEcCtD
Zanamivir—Dyspnoea—Gemcitabine—lung cancer	0.000887	0.00116	CcSEcCtD
Zanamivir—Nausea—Vinblastine—lung cancer	0.000885	0.00116	CcSEcCtD
Zanamivir—Convulsion—Paclitaxel—lung cancer	0.000885	0.00116	CcSEcCtD
Zanamivir—Anorexia—Cisplatin—lung cancer	0.000884	0.00116	CcSEcCtD
Zanamivir—Fatigue—Irinotecan—lung cancer	0.000881	0.00115	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00088	0.00115	CcSEcCtD
Zanamivir—Discomfort—Etoposide—lung cancer	0.000876	0.00115	CcSEcCtD
Zanamivir—Pain—Irinotecan—lung cancer	0.000874	0.00114	CcSEcCtD
Zanamivir—Arthralgia—Paclitaxel—lung cancer	0.000869	0.00114	CcSEcCtD
Zanamivir—Myalgia—Paclitaxel—lung cancer	0.000869	0.00114	CcSEcCtD
Zanamivir—NEU2—Metabolism—NCOA3—lung cancer	0.000868	0.00368	CbGpPWpGaD
Zanamivir—Anxiety—Paclitaxel—lung cancer	0.000866	0.00113	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—lung cancer	0.000866	0.00113	CcSEcCtD
Zanamivir—Decreased appetite—Gemcitabine—lung cancer	0.000865	0.00113	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000863	0.00113	CcSEcCtD
Zanamivir—Nausea—Topotecan—lung cancer	0.00086	0.00113	CcSEcCtD
Zanamivir—Discomfort—Paclitaxel—lung cancer	0.000859	0.00112	CcSEcCtD
Zanamivir—Fatigue—Gemcitabine—lung cancer	0.000858	0.00112	CcSEcCtD
Zanamivir—Confusional state—Etoposide—lung cancer	0.000857	0.00112	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000853	0.00362	CbGpPWpGaD
Zanamivir—Pain—Gemcitabine—lung cancer	0.000851	0.00111	CcSEcCtD
Zanamivir—Nausea—Erlotinib—lung cancer	0.000851	0.00111	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—lung cancer	0.00085	0.00111	CcSEcCtD
Zanamivir—Diarrhoea—Vinorelbine—lung cancer	0.000848	0.00111	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000845	0.00111	CcSEcCtD
Zanamivir—Infection—Etoposide—lung cancer	0.000844	0.0011	CcSEcCtD
Zanamivir—NEU2—Metabolism—ABCG2—lung cancer	0.000844	0.00358	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ADCY1—lung cancer	0.000844	0.00358	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP1—lung cancer	0.000844	0.00358	CbGpPWpGaD
Zanamivir—Feeling abnormal—Irinotecan—lung cancer	0.000842	0.0011	CcSEcCtD
Zanamivir—Confusional state—Paclitaxel—lung cancer	0.00084	0.0011	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—lung cancer	0.000837	0.0011	CcSEcCtD
Zanamivir—Gastrointestinal pain—Irinotecan—lung cancer	0.000835	0.00109	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—lung cancer	0.000834	0.00109	CcSEcCtD
Zanamivir—Anaphylactic shock—Paclitaxel—lung cancer	0.000833	0.00109	CcSEcCtD
Zanamivir—Infection—Paclitaxel—lung cancer	0.000828	0.00108	CcSEcCtD
Zanamivir—NEU2—Metabolism—HPGDS—lung cancer	0.000828	0.00351	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ENO2—lung cancer	0.000828	0.00351	CbGpPWpGaD
Zanamivir—Dyspnoea—Cisplatin—lung cancer	0.000827	0.00108	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—lung cancer	0.000825	0.00108	CcSEcCtD
Zanamivir—NEU2—Metabolism—PPP2R1B—lung cancer	0.000822	0.00349	CbGpPWpGaD
Zanamivir—Feeling abnormal—Gemcitabine—lung cancer	0.00082	0.00107	CcSEcCtD
Zanamivir—Shock—Paclitaxel—lung cancer	0.00082	0.00107	CcSEcCtD
Zanamivir—Dizziness—Vinorelbine—lung cancer	0.000819	0.00107	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000812	0.00344	CbGpPWpGaD
Zanamivir—Anorexia—Etoposide—lung cancer	0.00081	0.00106	CcSEcCtD
Zanamivir—Skin disorder—Paclitaxel—lung cancer	0.000809	0.00106	CcSEcCtD
Zanamivir—Body temperature increased—Irinotecan—lung cancer	0.000808	0.00106	CcSEcCtD
Zanamivir—Abdominal pain—Irinotecan—lung cancer	0.000808	0.00106	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000808	0.00106	CcSEcCtD
Zanamivir—Decreased appetite—Cisplatin—lung cancer	0.000806	0.00106	CcSEcCtD
Zanamivir—NEU2—Metabolism—GSTT1—lung cancer	0.000803	0.0034	CbGpPWpGaD
Zanamivir—Anorexia—Paclitaxel—lung cancer	0.000794	0.00104	CcSEcCtD
Zanamivir—NEU2—Metabolism—GCLC—lung cancer	0.000794	0.00337	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP2A6—lung cancer	0.000794	0.00337	CbGpPWpGaD
Zanamivir—Pain—Cisplatin—lung cancer	0.000793	0.00104	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000791	0.00104	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.00079	0.00335	CbGpPWpGaD
Zanamivir—Vomiting—Vinorelbine—lung cancer	0.000788	0.00103	CcSEcCtD
Zanamivir—Body temperature increased—Gemcitabine—lung cancer	0.000787	0.00103	CcSEcCtD
Zanamivir—Rash—Vinorelbine—lung cancer	0.000781	0.00102	CcSEcCtD
Zanamivir—Dermatitis—Vinorelbine—lung cancer	0.00078	0.00102	CcSEcCtD
Zanamivir—Headache—Vinorelbine—lung cancer	0.000776	0.00102	CcSEcCtD
Zanamivir—Syncope—Docetaxel—lung cancer	0.000776	0.00102	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—lung cancer	0.000775	0.00101	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—lung cancer	0.000775	0.00101	CcSEcCtD
Zanamivir—Feeling abnormal—Cisplatin—lung cancer	0.000764	0.001	CcSEcCtD
Zanamivir—Loss of consciousness—Docetaxel—lung cancer	0.000761	0.000995	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000759	0.000993	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—lung cancer	0.000758	0.000991	CcSEcCtD
Zanamivir—Cough—Docetaxel—lung cancer	0.000755	0.000988	CcSEcCtD
Zanamivir—Hypersensitivity—Irinotecan—lung cancer	0.000753	0.000985	CcSEcCtD
Zanamivir—NEU2—Metabolism—ENO1—lung cancer	0.000752	0.00319	CbGpPWpGaD
Zanamivir—Convulsion—Docetaxel—lung cancer	0.00075	0.000981	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000749	0.00318	CbGpPWpGaD
Zanamivir—Bronchitis—Doxorubicin—lung cancer	0.000745	0.000975	CcSEcCtD
Zanamivir—Dyspnoea—Paclitaxel—lung cancer	0.000743	0.000972	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.00074	0.00314	CbGpPWpGaD
Zanamivir—Decreased appetite—Etoposide—lung cancer	0.000739	0.000967	CcSEcCtD
Zanamivir—Myalgia—Docetaxel—lung cancer	0.000737	0.000964	CcSEcCtD
Zanamivir—Arthralgia—Docetaxel—lung cancer	0.000737	0.000964	CcSEcCtD
Zanamivir—Nausea—Vinorelbine—lung cancer	0.000736	0.000963	CcSEcCtD
Zanamivir—Body temperature increased—Cisplatin—lung cancer	0.000733	0.00096	CcSEcCtD
Zanamivir—Asthenia—Irinotecan—lung cancer	0.000733	0.000959	CcSEcCtD
Zanamivir—Fatigue—Etoposide—lung cancer	0.000733	0.000959	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000732	0.000957	CcSEcCtD
Zanamivir—Pain—Etoposide—lung cancer	0.000727	0.000951	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—lung cancer	0.000725	0.000948	CcSEcCtD
Zanamivir—Decreased appetite—Paclitaxel—lung cancer	0.000724	0.000948	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—lung cancer	0.00072	0.000942	CcSEcCtD
Zanamivir—Fatigue—Paclitaxel—lung cancer	0.000718	0.00094	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—lung cancer	0.000716	0.000938	CcSEcCtD
Zanamivir—Asthenia—Gemcitabine—lung cancer	0.000714	0.000934	CcSEcCtD
Zanamivir—Pain—Paclitaxel—lung cancer	0.000713	0.000932	CcSEcCtD
Zanamivir—Confusional state—Docetaxel—lung cancer	0.000712	0.000932	CcSEcCtD
Zanamivir—Anaphylactic shock—Docetaxel—lung cancer	0.000706	0.000924	CcSEcCtD
Zanamivir—Infection—Docetaxel—lung cancer	0.000702	0.000918	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—POMC—lung cancer	0.000701	0.00297	CbGpPWpGaD
Zanamivir—Feeling abnormal—Etoposide—lung cancer	0.0007	0.000916	CcSEcCtD
Zanamivir—Diarrhoea—Irinotecan—lung cancer	0.000699	0.000915	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—lung cancer	0.000695	0.000909	CcSEcCtD
Zanamivir—Shock—Docetaxel—lung cancer	0.000695	0.000909	CcSEcCtD
Zanamivir—Feeling abnormal—Paclitaxel—lung cancer	0.000687	0.000898	CcSEcCtD
Zanamivir—Skin disorder—Docetaxel—lung cancer	0.000686	0.000898	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000685	0.000897	CcSEcCtD
Zanamivir—Hypersensitivity—Cisplatin—lung cancer	0.000683	0.000894	CcSEcCtD
Zanamivir—Gastrointestinal pain—Paclitaxel—lung cancer	0.000681	0.000892	CcSEcCtD
Zanamivir—Diarrhoea—Gemcitabine—lung cancer	0.000681	0.000891	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—lung cancer	0.000677	0.000886	CcSEcCtD
Zanamivir—Dizziness—Irinotecan—lung cancer	0.000676	0.000884	CcSEcCtD
Zanamivir—Urticaria—Etoposide—lung cancer	0.000675	0.000883	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP2E1—lung cancer	0.000675	0.00286	CbGpPWpGaD
Zanamivir—Anorexia—Docetaxel—lung cancer	0.000673	0.000881	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—lung cancer	0.000672	0.000879	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—lung cancer	0.000672	0.000879	CcSEcCtD
Zanamivir—NEU2—Metabolism—NQO1—lung cancer	0.000667	0.00283	CbGpPWpGaD
Zanamivir—Asthenia—Cisplatin—lung cancer	0.000666	0.000871	CcSEcCtD
Zanamivir—Urticaria—Paclitaxel—lung cancer	0.000662	0.000866	CcSEcCtD
Zanamivir—Abdominal pain—Paclitaxel—lung cancer	0.000659	0.000862	CcSEcCtD
Zanamivir—Body temperature increased—Paclitaxel—lung cancer	0.000659	0.000862	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000653	0.00277	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP2—lung cancer	0.000653	0.00277	CbGpPWpGaD
Zanamivir—Vomiting—Irinotecan—lung cancer	0.00065	0.00085	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—lung cancer	0.000648	0.000848	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000647	0.00275	CbGpPWpGaD
Zanamivir—Rash—Irinotecan—lung cancer	0.000644	0.000843	CcSEcCtD
Zanamivir—Dermatitis—Irinotecan—lung cancer	0.000644	0.000842	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000643	0.000842	CcSEcCtD
Zanamivir—Chills—Methotrexate—lung cancer	0.000643	0.000841	CcSEcCtD
Zanamivir—Headache—Irinotecan—lung cancer	0.00064	0.000837	CcSEcCtD
Zanamivir—Diarrhoea—Cisplatin—lung cancer	0.000635	0.00083	CcSEcCtD
Zanamivir—Vomiting—Gemcitabine—lung cancer	0.000633	0.000828	CcSEcCtD
Zanamivir—Dyspnoea—Docetaxel—lung cancer	0.00063	0.000824	CcSEcCtD
Zanamivir—Rash—Gemcitabine—lung cancer	0.000627	0.000821	CcSEcCtD
Zanamivir—Dermatitis—Gemcitabine—lung cancer	0.000627	0.00082	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—lung cancer	0.000626	0.000819	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—lung cancer	0.000624	0.000816	CcSEcCtD
Zanamivir—Headache—Gemcitabine—lung cancer	0.000623	0.000816	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—lung cancer	0.00062	0.000812	CcSEcCtD
Zanamivir—Decreased appetite—Docetaxel—lung cancer	0.000614	0.000803	CcSEcCtD
Zanamivir—Hypersensitivity—Paclitaxel—lung cancer	0.000614	0.000803	CcSEcCtD
Zanamivir—Asthenia—Etoposide—lung cancer	0.00061	0.000798	CcSEcCtD
Zanamivir—Fatigue—Docetaxel—lung cancer	0.000609	0.000797	CcSEcCtD
Zanamivir—Nausea—Irinotecan—lung cancer	0.000607	0.000794	CcSEcCtD
Zanamivir—Pain—Docetaxel—lung cancer	0.000604	0.00079	CcSEcCtD
Zanamivir—NEU2—Metabolism—STK11—lung cancer	0.000601	0.00255	CbGpPWpGaD
Zanamivir—Asthenia—Paclitaxel—lung cancer	0.000598	0.000782	CcSEcCtD
Zanamivir—Nausea—Gemcitabine—lung cancer	0.000591	0.000774	CcSEcCtD
Zanamivir—Vomiting—Cisplatin—lung cancer	0.00059	0.000772	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—lung cancer	0.000587	0.000768	CcSEcCtD
Zanamivir—Rash—Cisplatin—lung cancer	0.000585	0.000765	CcSEcCtD
Zanamivir—Dermatitis—Cisplatin—lung cancer	0.000584	0.000765	CcSEcCtD
Zanamivir—Feeling abnormal—Docetaxel—lung cancer	0.000582	0.000762	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—lung cancer	0.000581	0.000761	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—lung cancer	0.000579	0.000757	CcSEcCtD
Zanamivir—Gastrointestinal pain—Docetaxel—lung cancer	0.000578	0.000756	CcSEcCtD
Zanamivir—Diarrhoea—Paclitaxel—lung cancer	0.00057	0.000746	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000565	0.00239	CbGpPWpGaD
Zanamivir—Malaise—Methotrexate—lung cancer	0.000562	0.000736	CcSEcCtD
Zanamivir—Dizziness—Etoposide—lung cancer	0.000562	0.000735	CcSEcCtD
Zanamivir—Body temperature increased—Docetaxel—lung cancer	0.000558	0.000731	CcSEcCtD
Zanamivir—Abdominal pain—Docetaxel—lung cancer	0.000558	0.000731	CcSEcCtD
Zanamivir—Chills—Doxorubicin—lung cancer	0.000557	0.000728	CcSEcCtD
Zanamivir—NEU2—Metabolism—GSTP1—lung cancer	0.000556	0.00236	CbGpPWpGaD
Zanamivir—Arrhythmia—Doxorubicin—lung cancer	0.000554	0.000725	CcSEcCtD
Zanamivir—Dizziness—Paclitaxel—lung cancer	0.000551	0.000721	CcSEcCtD
Zanamivir—Nausea—Cisplatin—lung cancer	0.000551	0.000721	CcSEcCtD
Zanamivir—Cough—Methotrexate—lung cancer	0.000544	0.000712	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—CXCL8—lung cancer	0.000542	0.0023	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CAT—lung cancer	0.000541	0.0023	CbGpPWpGaD
Zanamivir—Convulsion—Methotrexate—lung cancer	0.00054	0.000707	CcSEcCtD
Zanamivir—Vomiting—Etoposide—lung cancer	0.00054	0.000707	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000538	0.00228	CbGpPWpGaD
Zanamivir—Rash—Etoposide—lung cancer	0.000536	0.000701	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—lung cancer	0.000535	0.0007	CcSEcCtD
Zanamivir—Headache—Etoposide—lung cancer	0.000532	0.000697	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—lung cancer	0.000531	0.000695	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—lung cancer	0.000531	0.000695	CcSEcCtD
Zanamivir—Vomiting—Paclitaxel—lung cancer	0.00053	0.000693	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000527	0.00069	CcSEcCtD
Zanamivir—NEU2—Metabolism—ABCB1—lung cancer	0.000527	0.00223	CbGpPWpGaD
Zanamivir—Rash—Paclitaxel—lung cancer	0.000525	0.000687	CcSEcCtD
Zanamivir—Dermatitis—Paclitaxel—lung cancer	0.000525	0.000687	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—lung cancer	0.000525	0.000686	CcSEcCtD
Zanamivir—Headache—Paclitaxel—lung cancer	0.000522	0.000683	CcSEcCtD
Zanamivir—Hypersensitivity—Docetaxel—lung cancer	0.00052	0.000681	CcSEcCtD
Zanamivir—NEU2—Metabolism—TYMS—lung cancer	0.000517	0.00219	CbGpPWpGaD
Zanamivir—Confusional state—Methotrexate—lung cancer	0.000513	0.000672	CcSEcCtD
Zanamivir—NEU2—Metabolism—GSTM1—lung cancer	0.000511	0.00217	CbGpPWpGaD
Zanamivir—Anaphylactic shock—Methotrexate—lung cancer	0.000509	0.000666	CcSEcCtD
Zanamivir—Asthenia—Docetaxel—lung cancer	0.000507	0.000663	CcSEcCtD
Zanamivir—Infection—Methotrexate—lung cancer	0.000506	0.000662	CcSEcCtD
Zanamivir—Nausea—Etoposide—lung cancer	0.000505	0.000661	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—lung cancer	0.000501	0.000656	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—lung cancer	0.000496	0.000649	CcSEcCtD
Zanamivir—Nausea—Paclitaxel—lung cancer	0.000495	0.000648	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—lung cancer	0.000494	0.000647	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—lung cancer	0.000487	0.000637	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—lung cancer	0.000485	0.000635	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP1A1—lung cancer	0.000485	0.00206	CbGpPWpGaD
Zanamivir—Syncope—Doxorubicin—lung cancer	0.000484	0.000634	CcSEcCtD
Zanamivir—Diarrhoea—Docetaxel—lung cancer	0.000483	0.000632	CcSEcCtD
Zanamivir—NEU2—Metabolism—ERCC2—lung cancer	0.000481	0.00204	CbGpPWpGaD
Zanamivir—Loss of consciousness—Doxorubicin—lung cancer	0.000475	0.000621	CcSEcCtD
Zanamivir—Cough—Doxorubicin—lung cancer	0.000471	0.000617	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—lung cancer	0.000468	0.000612	CcSEcCtD
Zanamivir—Dizziness—Docetaxel—lung cancer	0.000467	0.000611	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000464	0.000607	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—lung cancer	0.00046	0.000602	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—lung cancer	0.00046	0.000602	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—lung cancer	0.000458	0.0006	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000457	0.000597	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—lung cancer	0.000454	0.000594	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—lung cancer	0.000454	0.000594	CcSEcCtD
Zanamivir—Vomiting—Docetaxel—lung cancer	0.000449	0.000588	CcSEcCtD
Zanamivir—Rash—Docetaxel—lung cancer	0.000445	0.000583	CcSEcCtD
Zanamivir—Dermatitis—Docetaxel—lung cancer	0.000445	0.000582	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—lung cancer	0.000444	0.000582	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—lung cancer	0.000442	0.000579	CcSEcCtD
Zanamivir—Headache—Docetaxel—lung cancer	0.000442	0.000579	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—lung cancer	0.000441	0.000577	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—lung cancer	0.000439	0.000574	CcSEcCtD
Zanamivir—Infection—Doxorubicin—lung cancer	0.000438	0.000573	CcSEcCtD
Zanamivir—Pain—Methotrexate—lung cancer	0.000435	0.00057	CcSEcCtD
Zanamivir—Shock—Doxorubicin—lung cancer	0.000434	0.000567	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—lung cancer	0.000428	0.00056	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—lung cancer	0.00042	0.00055	CcSEcCtD
Zanamivir—Nausea—Docetaxel—lung cancer	0.00042	0.000549	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—lung cancer	0.000419	0.000549	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—lung cancer	0.000416	0.000545	CcSEcCtD
Zanamivir—NEU2—Metabolism—APOA1—lung cancer	0.000416	0.00176	CbGpPWpGaD
Zanamivir—Urticaria—Methotrexate—lung cancer	0.000404	0.000529	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—lung cancer	0.000402	0.000527	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—lung cancer	0.000402	0.000527	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000402	0.000525	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.000398	0.00169	CbGpPWpGaD
Zanamivir—Dyspnoea—Doxorubicin—lung cancer	0.000393	0.000514	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—lung cancer	0.000383	0.000501	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—lung cancer	0.00038	0.000497	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CG—lung cancer	0.00038	0.00161	CbGpPWpGaD
Zanamivir—Pain—Doxorubicin—lung cancer	0.000377	0.000493	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—lung cancer	0.000375	0.000491	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—lung cancer	0.000365	0.000478	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—lung cancer	0.000363	0.000475	CcSEcCtD
Zanamivir—NEU2—Metabolism—POMC—lung cancer	0.000361	0.00153	CbGpPWpGaD
Zanamivir—Gastrointestinal pain—Doxorubicin—lung cancer	0.00036	0.000472	CcSEcCtD
Zanamivir—NEU2—Metabolism—CREBBP—lung cancer	0.000352	0.00149	CbGpPWpGaD
Zanamivir—Urticaria—Doxorubicin—lung cancer	0.00035	0.000458	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—lung cancer	0.000348	0.000456	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—lung cancer	0.000348	0.000456	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—lung cancer	0.000348	0.000456	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—lung cancer	0.000337	0.00044	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CD—lung cancer	0.000334	0.00142	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALB—lung cancer	0.00033	0.0014	CbGpPWpGaD
Zanamivir—Hypersensitivity—Doxorubicin—lung cancer	0.000325	0.000425	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—lung cancer	0.000324	0.000423	CcSEcCtD
Zanamivir—Rash—Methotrexate—lung cancer	0.000321	0.00042	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—lung cancer	0.000321	0.00042	CcSEcCtD
Zanamivir—Headache—Methotrexate—lung cancer	0.000319	0.000417	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—lung cancer	0.000316	0.000414	CcSEcCtD
Zanamivir—Nausea—Methotrexate—lung cancer	0.000302	0.000396	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—lung cancer	0.000302	0.000395	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—lung cancer	0.000291	0.000381	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CB—lung cancer	0.000291	0.00123	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS2—lung cancer	0.000288	0.00122	CbGpPWpGaD
Zanamivir—Vomiting—Doxorubicin—lung cancer	0.00028	0.000367	CcSEcCtD
Zanamivir—Rash—Doxorubicin—lung cancer	0.000278	0.000364	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—lung cancer	0.000278	0.000363	CcSEcCtD
Zanamivir—Headache—Doxorubicin—lung cancer	0.000276	0.000361	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—lung cancer	0.000262	0.000343	CcSEcCtD
Zanamivir—NEU2—Metabolism—PTEN—lung cancer	0.000251	0.00107	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—EP300—lung cancer	0.00024	0.00102	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PIK3CA—lung cancer	0.000177	0.000752	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AKT1—lung cancer	0.000145	0.000615	CbGpPWpGaD
